Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Dewpoint Therapeutics is a leading biotechnology company focused on translating condensate biology into novel therapies. By understanding that the dysregulation of biomolecular condensates is the…

Dewpoint Therapeutics is a leading biotechnology company focused on translating condensate biology into novel therapies. By understanding that the dysregulation of biomolecular condensates is the…
Founded: 2018
Headquarters: Boston, Massachusetts
Focus: Drug discovery targeting biomolecular condensates
Notable investors: Polaris Partners, ARCH Venture Partners, SoftBank Vision Fund, Leaps by Bayer
Reported funding: $150M Series C (2022); multiple prior rounds including $60M Series A (2019)
Translating condensate biology into therapeutics for oncology, neurodegeneration, ALS and cardiovascular diseases.
2018
Biotechnology
$60,000,000
Launch/Series A announced at company formation
$150,000,000
Reported Series C financing
Later funding activity listed with this date in public profiles
“Polaris Partners, ARCH Venture Partners, SoftBank Vision Fund, Leaps by Bayer, Samsara BioCapital, 6 Dimensions Capital, EcoR1 Capital, Alexandria Venture Investments”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week